Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R12-8). We employs the Retrovirus (pUC-mKate-IL-17-BamHI) vector components and the SynExpress system of the exons Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R12-8
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
mKate
Promoter
pUC
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.92
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.